Stefan Glombitza
Chief Executive Officer at FORMYCON AG
Stefan Glombitza active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FORMYCON AG | Chief Executive Officer | 2022-06-30 | - |
| Chief Operating Officer | 2016-09-30 | 2022-06-30 |
Career history of Stefan Glombitza
Former positions of Stefan Glombitza
| Companies | Position | Start | End |
|---|---|---|---|
| Hexal Pharmaforschung GmbH | Corporate Officer/Principal | - | - |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | 1994-12-31 | - |
Training of Stefan Glombitza
| University of Regensburg | Doctorate Degree |
Statistics
International
| Germany | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Private companies | 2 |
|---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
| Hexal Pharmaforschung GmbH |
- Stock Market
- Insiders
- Stefan Glombitza
- Experience
